NeuroBo Pharmaceuticals, Inc. (NRBO) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts NRBO Hot Sheet
Join SI Premium – FREE
NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) reported Q3 EPS of ($0.09), $0.02 better than the analyst estimate of ($0.11).
For earnings history and earnings-related data on NeuroBo Pharmaceuticals, Inc. (NRBO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
